Product Categories
Sun Protection
Sunscreens combine tightly controlled UV filters, a measured performance claim and an international cosmetic-versus-drug split. The Annex VI positive list, the homosalate, benzophenone-3 and octocrylene restrictions, nano filters, and SPF and UVA testing.
Sun protection is one of the most demanding cosmetic categories, because three hard requirements meet in a single product: the UV filters are tightly controlled actives, the SPF is a measured performance claim that has to be substantiated, and the product sits on the cosmetic-versus-drug line differently in different countries.
UV filters and the Annex VI positive list
Only UV filters listed in Annex VI may be used, each at a maximum concentration and under set conditions, and that list has been moving. Homosalate was restricted by Commission Regulation (EU) 2022/2195 to face products only (excluding propellant sprays) at a maximum of 7.34%, applying from 1 January 2025. Benzophenone-3 and octocrylene were cut by Commission Regulation (EU) 2022/1176: benzophenone-3 to 6% in face, hand and lip products and 2.2% in body products, with lower limits again where it is also used at 0.5% to protect the formulation, and a βcontains Benzophenone-3β warning in that case. The UV filter 4-methylbenzylidene camphor has been banned. These changes followed SCCS opinions raising endocrine-disruption concerns, and because each filter is capped, reaching a high SPF means combining several filters so that each stays within its limit.
Nano filters
Nanoform titanium dioxide and zinc oxide are widely used mineral filters, but the nanoform requires notification to the Commission under Article 16 six months before marketing and is permitted only under the specific conditions in the Annex VI nano entries, not in sprayable or otherwise inhalable applications. The physical form of the filter is therefore part of the assessment, not a formulation detail.
SPF and UVA testing
The protection claim has to be earned by testing. SPF is determined in vivo to ISO 24444, UVA protection in vitro to ISO 24443, and water resistance by its own method. The European Commission Recommendation 2006/647/EC frames the claims: UVA protection should be at least a third of the labelled SPF, shown by the UVA-in-a-circle symbol, and SPF is communicated through the low, medium, high and very high categories rather than misleading figures. The label has to match the tested performance.
International divergence
A sunscreen compliant in the EU is not automatically sellable elsewhere. In the United States sunscreens are over-the-counter drugs regulated under an FDA monograph with its own, older list of permitted filters, and in Australia they are therapeutic goods under the TGA. The same formula can therefore need a different filter system and a different regulatory route per market, which is central to planning an international sun-care launch.
How we help
We assess the filter system against the current Annex VI limits, advise on combining filters to reach the target SPF, handle the Article 16 notification for nanoforms, and make sure the SPF, UVA and water-resistance claims rest on the right tests under the right standards. Where a sunscreen is destined for the US or Australia, we flag the drug or therapeutic-goods pathway early so the filter choice suits every market from the outset.
Relevant services
CPSR
From Β£70 Β· 2 to 3 days
The Cosmetic Product Safety Report is the safety assessment required under Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product may be placed on the UK or EU market. Prepared and signed by a qualified safety assessor.
Learn more βTesting
From Β£75
Stability, microbiology, photoprotection and analytical testing carried out in our three in-house laboratories. Analytical work is not contracted out; results pass directly to the assessor preparing your CPSR.
Learn more βLabelling
From Β£195 Β· from receipt of artwork
Independent review of packaging artwork against Article 19, and of product claims against the six Common Criteria of Regulation (EU) 655/2013. Label review Β£195; per-claim review from Β£125; substantiation dossiers from Β£1,495.
Learn more βFrequently asked questions
What are the EU restrictions on sunscreen UV filters?
In the EU, only UV filters listed in Annex VI may be used, at set limits. Homosalate is now restricted to face products at 7.34% (Regulation 2022/2195), and benzophenone-3 and octocrylene were cut by Regulation 2022/1176 (BP-3 to 6% face / 2.2% body). 4-MBC is banned. Nanoform filters need Article 16 notification.
How is a sunscreen's SPF and UVA protection tested?
In the EU and UK, SPF is measured in vivo to ISO 24444 and UVA protection in vitro to ISO 24443, with water resistance by its own method. EU Recommendation 2006/647/EC requires UVA protection of at least a third of the labelled SPF, shown by the UVA-in-a-circle symbol, with SPF communicated in categories from low to very high.
What is a CPSR?
A Cosmetic Product Safety Report (CPSR) is the safety assessment required by Article 10 and Annex I of Regulation (EC) No 1223/2009 before a cosmetic product is placed on the UK or EU market. Annex I sets out two parts: Part A, the cosmetic product safety information (composition, physico-chemical and microbiological characteristics, stability, exposure and the toxicological profile of each substance), and Part B, the safety assessment, in which a qualified assessor states and reasons the conclusion on safety. It is the pivotal scientific document held within the Product Information File.
Which cosmetics are regulated as OTC drugs in the United States?
Sunscreens, anti-dandruff shampoos, anticavity (fluoride) toothpastes, antiperspirants, acne treatments and skin protectants are over-the-counter drugs in the US, regulated under FDA monographs rather than as cosmetics, so they fall outside the cosmetic MoCRA pathway.
Do nanomaterials in cosmetics need a separate notification in the EU?
In the EU, yes: under Article 16 of Regulation 1223/2009 a cosmetic containing a nanomaterial must be notified to the European Commission six months before being placed on the market, in addition to the standard CPNP notification, with safety data specific to the nano form.